Insulin degludec is a new ultra-long-acting insulin analogue

Achieving optimal glycemic control is an important aspect of preventing and slowing the progression of diabetes-associated complications, and reducing the cost of their treatment. Long-acting insulin analogues, glargine and detemir, provide better metabolic control with reduced risk of hypoglycaemia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2014
Materias:
Acceso en línea:https://doaj.org/article/6e417b1bfcf04a568b284fe7ce6e9f5f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!